HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice

Authors

Alison K. Esser, Washington University School of Medicine in St. Louis
Daniel A. Rauch, Washington University School of Medicine in St. Louis
Jingyu Xiang, Washington University School of Medicine in St. Louis
John C. Harding, Washington University School of Medicine in St. Louis
Michael H. Ross, Washington University School of Medicine in St. Louis
Xinming Su, Washington University School of Medicine in St. Louis
Kevin Wu, Washington University School of Medicine in St. Louis
Yalin Xu, Washington University School of Medicine in St. Louis
Kiran Vij, Washington University School of Medicine in St. Louis
Lee Ratner, Washington University School of Medicine in St. Louis
Katherine N. Weilbaecher, Washington University School of Medicine in St. Louis
et al

Journal

Oncotarget

Publication Date

2017

Volume

8

Issue

41

Inclusive Pages

69250-69263

Document Type

Open Access Publication

DOI

10.18632/oncotarget.20565

Rights and Permissions

Esser, A. K., Rauch, D. A., Xiang, J., Harding, J. C., Kohart, N. A., Ross, M. H., . . . Weilbaecher, K. N. (2017). HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget, 8(41), 69250-69263. doi:10.18632/oncotarget.20565.

Recommended Citation

Esser, Alison K.; Rauch, Daniel A.; Xiang, Jingyu; Harding, John C.; Ross, Michael H.; Su, Xinming; Wu, Kevin; Xu, Yalin; Vij, Kiran; Ratner, Lee; Weilbaecher, Katherine N.; and et al, "HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice." Oncotarget. 8, 41. 69250-69263. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6265